During the last session, Fractyl Health Inc (NASDAQ:GUTS)’s traded shares were 0.44 million. At the end of the trading day, the stock’s price was $2.04, reflecting an intraday loss of -7.48% or -$0.16. The 52-week high for the GUTS share is $14.50, that puts it down -610.78 from that peak though still a striking 14.71% gain since the share price plummeted to a 52-week low of $1.74. The company’s market capitalization is $98.12M, and the average intraday trading volume over the past 10 days was 0.24 million shares, and the average trade volume was 352.91K shares over the past three months.
Fractyl Health Inc (GUTS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. GUTS has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
Fractyl Health Inc (NASDAQ:GUTS) trade information
Fractyl Health Inc (GUTS) registered a -7.48% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -7.48% in intraday trading to $2.04, hitting a weekly high. The stock’s 5-day price performance is -11.69%, and it has moved by -13.92% in 30 days. The short interest in Fractyl Health Inc (NASDAQ:GUTS) is 2.24 million shares and it means that shorts have 5.48 day(s) to cover.
Fractyl Health Inc (GUTS) estimates and forecasts
Statistics show that Fractyl Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Fractyl Health Inc (GUTS) shares have gone down -63.83% during the last six months, with a year-to-date growth rate more than the industry average at 94.83% against 16.40.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -126.07%. While earnings are projected to return 96.33% in 2024.
GUTS Dividends
Fractyl Health Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
